Zhang Ye, Huang Zehao, Xu Meng, Liu Jie, Li Zhengjiang, An Changming, Liu Shaoyan, Wang Xiaolei
Department of Head and Neck Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Ann Transl Med. 2022 May;10(9):525. doi: 10.21037/atm-22-1844.
Salvage surgery for hypopharyngeal squamous cell carcinoma (HPSCC) after radiotherapy may result in several postoperative complications and the oncological outcome is unsatisfying. Therefore, identifying the risk factors for postoperative complications and oncological outcome after salvage surgery is important. This study aimed to determine which HPSCC patients might benefit from salvage surgery following previous radiotherapy.
We retrospectively analyzed 91 HPSCC patients who underwent salvage surgery due to locoregional recurrence/residual disease after radiotherapy. The pre- and intraoperative characteristics with complications and oncological outcomes were collected through medical records and telephone follow-up. Risk factors for complications were analyzed by binary logistic regression. The oncological outcomes were assessed by overall survival (OS) after salvage surgery. Kaplan-Meier curves and Cox proportional hazard regression analysis were used for univariate and multivariate survival analyses.
Postoperative complications occurred in 40.7% of patients, with pharyngo-cutaneous fistula (PCF) occurring in 29.7% of patients. Salvage surgery for local disease was the only independent risk factor for postoperative complications and PCF [complications: odds ratio (OR) =5.298, 95% confidence interval (CI): 1.163-24.130, P=0.031; PCF: OR =4.543, 95% CI: 1.187-17.387, P=0.027). In the subgroup of patients with local disease, time of curative treatment initiation >90 days (OR =7.331, 95% CI: 1.278-42.054, P=0.025) and preoperative hemoglobin <118 g/L (OR =10.101, 95% CI: 1.026-99.492, P=0.045) were independent risk factors for postoperative complications, while free flap reconstruction was an independent protective factor for PCF (OR =0.099, 95% CI: 0.010-0.934, P=0.043). The median OS time was 17 months, with 5-year OS rates of 30%. Age at salvage surgery <50 years [hazard ratio (HR) =2.047, 95% CI: 1.217-3.443, P=0.007] and recurrence or retreatment clinical T stage 3-4 (rcT3-4) (HR =2.051, 95% CI: 1.219-3.450, P=0.007) were identified as risk factors for OS. The 5-year OS rates of patients without and with both risk factors were 43% and 10% (P=0.001).
Salvage surgery for locoregional recurrence/residual disease after previous radiotherapy could improve survival in selected patients with HPSCC. Patients with local recurrence/residual disease had a higher complication rate. Efforts can be made to shorten the time of curative treatment initiation and treat anemia to reduce the risk of postoperative complications in this subgroup.
下咽鳞状细胞癌(HPSCC)放疗后挽救性手术可能导致多种术后并发症,且肿瘤学结局并不理想。因此,识别挽救性手术后术后并发症和肿瘤学结局的危险因素很重要。本研究旨在确定哪些HPSCC患者可能从既往放疗后的挽救性手术中获益。
我们回顾性分析了91例因放疗后局部区域复发/残留疾病而接受挽救性手术的HPSCC患者。通过病历和电话随访收集术前及术中伴有并发症和肿瘤学结局的特征。采用二元逻辑回归分析并发症的危险因素。通过挽救性手术后的总生存期(OS)评估肿瘤学结局。采用Kaplan-Meier曲线和Cox比例风险回归分析进行单因素和多因素生存分析。
40.7%的患者发生术后并发症,29.7%的患者发生咽皮肤瘘(PCF)。局部疾病的挽救性手术是术后并发症和PCF的唯一独立危险因素[并发症:比值比(OR)=5.298,95%置信区间(CI):1.163 - 24.130,P = 0.031;PCF:OR = 4.543,95% CI:1.187 - 17.387,P = 0.027]。在局部疾病患者亚组中,根治性治疗开始时间>90天(OR = 7.331,95% CI:1.278 - 42.054,P = 0.025)和术前血红蛋白<118 g/L(OR = 10.101,95% CI:1.026 - 99.492,P = 0.045)是术后并发症的独立危险因素,而游离皮瓣重建是PCF的独立保护因素(OR = 0.099,95% CI:0.010 - 0.934,P = 0.043)。中位OS时间为17个月,5年OS率为30%。挽救性手术时年龄<50岁[风险比(HR)= 2.047,95% CI:1.217 - 3.443,P = 0.007]和复发或再次治疗临床T分期3 - 4期(rcT3 - 4)(HR = 2.051,95% CI:1.219 - 3.450,P = 0.007)被确定为OS的危险因素。无这两个危险因素和有这两个危险因素患者的5年OS率分别为43%和10%(P = 0.001)。
既往放疗后局部区域复发/残留疾病的挽救性手术可改善部分HPSCC患者的生存。局部复发/残留疾病患者的并发症发生率较高。可努力缩短根治性治疗开始时间并治疗贫血,以降低该亚组患者术后并发症的风险。